Ripasudil dihydrate is a chemical compound primarily used in the treatment of glaucoma and ocular hypertension. It functions as a Rho kinase inhibitor, which helps to lower intraocular pressure by enhancing the outflow of aqueous humor from the eye. The dihydrate form indicates that the compound contains two molecules of water per molecule of Ripasudil, which can influence its solubility and stability. In terms of physical characteristics, Ripasudil dihydrate is typically a white to off-white crystalline powder. Its molecular structure includes specific functional groups that contribute to its pharmacological activity. The compound is administered topically as an eye drop solution, and its efficacy is supported by clinical studies. Safety and side effects are also monitored, as with any pharmaceutical agent, to ensure patient well-being. Overall, Ripasudil dihydrate represents a significant advancement in glaucoma therapy, providing an alternative mechanism of action compared to traditional treatments.

Ripasudil dihydrate

Find at CymitQuimica all products linked to CAS 887375-67-9. Enter now to get more information

(S)-4-Fluoro-5-((2-Methyl-1,4-Diazepan-1-Yl)Sulfonyl)Isoquinoline Hydrochloride Dihydrate

CAS 887375-67-9: Ripasudil dihydrate

(S)-4-Fluoro-5-((2-Methyl-1,4-Diazepan-1-Yl)Sulfonyl)Isoquinoline Hydrochloride Dihydrate

Ref: 54-PC108715

K115

Ref: 10-F468383

K115

Ref: IN-DA00GU3V

Ripasudil HCl hydrate

Ref: 3D-FR162274